---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-039582"
form_type: "8-K"
ticker: "PMHS"
cik: "0001265521"
company_name: "Polomar Health Services, Inc."
filed_at: "2024-10-04T23:59:59+00:00"
generated_at: "2026-05-30T19:51:52.342496+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Trustfeed Corp. completes reverse merger acquisition of Polomar Specialty Pharmacy

## Summary
- Acquired 100% of Polomar Specialty Pharmacy in exchange for ~207.4M shares of common stock.
- Majority owner CWR 1 canceled 50M shares pre-closing; former Polomar members own ~75% of combined company.
- Trustfeed will now operate as a Florida-licensed compounding pharmacy, including SlimRx weight-loss platform.
- Entered into IP license with Pinata Holdings for proprietary drug delivery of metformin, semaglutide, etc.
- Financial statements to be filed as amendment within 71 days of filing date.

## SEC filing metadata
- accession: 0001493152-24-039582
- form_type: 8-K
- ticker: PMHS
- cik: 0001265521
- company_name: Polomar Health Services, Inc.
- filed_at: 2024-10-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.01, 3.02, 5.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1265521/000149315224039582/0001493152-24-039582-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1265521/000149315224039582/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-039582
- JSON: https://secwatch.observer/filing/0001493152-24-039582.json
- Plain text: https://secwatch.observer/filing/0001493152-24-039582.txt

## Key facts
- M&A Transactions
  Polomar Health Services, Inc. completed an acquisition involving Polomar for approximately 207,414,147 shares of our common stock (closed 2024-09-30).
  - Action: acquisition
  - Counterparty: Polomar
  - Consideration: approximately 207,414,147 shares of our common stock
  - Closing: 2024-09-30
  source text: right to receive 2,074,141.47 shares of our common stock, with all fractional shares rounded up to the nearest whole share. Accordingly, we issued an aggregate of approximately 207,414,147 shares of our common stock for all of the then-outstanding Polomar Membership Interests. Directors and Officers of the Company In connection with the Acquisition, all of the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1265521/000149315224039582/0001493152-24-039582-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.